Thus, this study sought to (a) further investigate the influence of patients’ baseline characteristics and plasma exposure of four anti-TB drugs on the reduction in the serum CRP levels in response to treatment onset and (b) determine whether these patterns of serum CRP reduction are linked to the treatment response in Latvian patients with drug-susceptible pulmonary tuberculosis (DS-PTB). The gene discussed is CRP; the disease is tuberculosis.